SWDCF (Swedencare AB) Common Stock : $0.2 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Swedencare AB Common Stock?

Swedencare AB's quarterly common stock declined from Mar. 2024 ($0.2 Mil) to Jun. 2024 ($0.2 Mil) but then increased from Jun. 2024 ($0.2 Mil) to Sep. 2024 ($0.2 Mil).

Swedencare AB's annual common stock increased from Dec. 2021 ($0.1 Mil) to Dec. 2022 ($0.2 Mil) and increased from Dec. 2022 ($0.2 Mil) to Dec. 2023 ($0.2 Mil).

Swedencare AB Common Stock Historical Data

The historical data trend for Swedencare AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Swedencare AB Common Stock Chart

Swedencare AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.08

0.13

0.15

0.16

Swedencare AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															0.14	0.16	0.15	0.15	0.16

Swedencare AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Swedencare AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Swedencare AB (OTCPK:SWDCF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

SECARE:Sweden 0ABG:UK 7XY:Germany

Address

Per Albin Hanssons Vag 41, Medeon Science Park, Malmo, SWE, 214 32

Website

https://www.swedencare.se

Swedencare AB specializes in pet healthcare and produces partly in its factories, markets, and sells premium products on the global market. The company has a wide range of brands and products within most therapy areas, which includes Animal Pharmaceuticals, nutravet, NutriScience, PetMD, Stratford, VetWELL as well as ProDen PlaqueOff for oral health to dogs and cats. The company's products are sold in approximately fifty markets.